CIK 0000850261
SRNE Sorrento Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Mar 20, 2023.
In brief
Sorrento Therapeutics, Inc. (SRNE) has 3 SEC Form 4 filings on file from 1 insider, the latest filed on Mar 20, 2023. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Sorrento Therapeutics, Inc., scored.
Transactions
Every row filed, 7 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2023 | Henry Ji See Remarks | XIn-the-money exercise Common Stockindirect: By BioVintage, Inc. | +19,500 | $0.80 | $16k | 20,000 | Mar 20, 2023 |
| Mar 17, 2023 | Henry Ji See Remarks | DDisposition to issuer Put Option (obligation to buy)derivativeindirect: By BioVintage, Inc. | -195 | $0.00 | $0 | 0 | Mar 20, 2023 |
| Dec 2, 2022 | Henry Ji See Remarks | XIn-the-money exercise Common Stockindirect: By BioVintage, Inc. | +200 | $5.50 | $1,100 | 200 | Dec 23, 2022 |
| Dec 21, 2022 | Henry Ji See Remarks | XIn-the-money exercise Common Stockindirect: By BioVintage, Inc. | +300 | $5.50 | $1,650 | 500 | Dec 23, 2022 |
| Dec 2, 2022 | Henry Ji See Remarks | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: By BioVintage, Inc. | -2 | $0.00 | $0 | 198 | Dec 23, 2022 |
| Dec 21, 2022 | Henry Ji See Remarks | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: By BioVintage, Inc. | -3 | $0.00 | $0 | 195 | Dec 23, 2022 |
| Dec 15, 2022 | Henry Ji See Remarks | AGrant or award Common Stock | +1,500,000 | $0.00 | $0 | 6,265,805 | Dec 16, 2022 |
Questions about SRNE
Answered from the filings on this page, as of the latest one.
Are insiders buying SRNE?
No. In the last 90 days no insider at Sorrento Therapeutics, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade SRNE on the open market?
No open-market trade has been scored at Sorrento Therapeutics, Inc.. The latest Form 4 on file was filed on Mar 20, 2023 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Sorrento Therapeutics, Inc.?
1 person has filed a Form 4 at Sorrento Therapeutics, Inc., among them Henry Ji (See Remarks). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.